Human Genome Epidemiology Literature Finder
|
Records 1 - 13 (of 13 Records) |
| Query Trace: Pericardial Effusion and EGFR[original query] |
|---|
| EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma. Cellular oncology (Dordrecht) 2012 Jun 35 (3): 189-96. Smits Alexander J J, Kummer J Alain, Hinrichs John W J, Herder Gerarda J M, Scheidel-Jacobse Karen C, Jiwa N Mehdi, Ruijter T Emiel G, Nooijen Peet T G A, Looijen-Salamon Monica G, Ligtenberg Marjolijn J L, Thunnissen Frederik B, Heideman Daniëlle A M, de Weger Roel A, Vink Ary |
| Erlotinib for Japanese patients with activating EGFR mutation-positive non-small-cell lung cancer: combined analyses from two Phase II studies. Future oncology (London, England) 2016 Jun . Atagi Shinji, Goto Koichi, Seto Takashi, Yamamoto Nobuyuki, Tamura Tomohide, Tajima Kosei, Inagaki Naohi |
| [Clinical Observation of Gefitinib with Pericardial Perfusion for ?Advanced Non-small Cell Lung Cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2018 1 21 (1): 37-42. Wang Xiaomeng, Chen Jin, Yao Jiaqi, Guo Renh |
| Prognosis of EGFR-mutant advanced lung adenocarcinoma patients with different intrathoracic metastatic patterns. Journal of Cancer 2019 3 10 (5): 1254-1262. Hu Fang, Zhang Bo, Li Changhui, Xu Jianlin, Wang Huimin, Gu Ping, Zheng Xiaoxuan, Nie Wei, Shen Yinchen, Zhang Hai, Hu Ping, Zhang Xuey |
| Prognostic factors of EGFR-mutated metastatic adenocarcinoma of lung. European journal of radiology 2019 Dec 123 108780. Ng Kwok Sing, King Sun Chu, Boom Ting Kung, Ting Kun Au Yo |
| Analysis of multigene detection in patients with advanced lung adenocarcinoma using cytological specimens. Pathology, research and practice 2020 7 216 (8): 153036. Ma Yang, Du Yun, Wang Rui, Ji Xiaokun, Wu Juan, Liu Ying, Guo Xiao, Zhang Y |
| Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS). JACC. CardioOncology 2021 8 1 (2): 172-178. Anand Kartik, Ensor Joe, Trachtenberg Barry, Bernicker Eric |
| Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study. The Lancet. Respiratory medicine 2021 Mar . Shi Yuankai, Hu Xingsheng, Zhang Shucai, Lv Dongqing, Wu Lin, Yu Qitao, Zhang Yiping, Liu Li, Wang Xiang, Cheng Ying, Ma Zhiyong, Niu Hongrui, Wang Dong, Feng Jifeng, Huang Cheng, Liu Chunling, Zhao Hui, Li Jingzhang, Zhang Xiaodong, Jiang Yong, Gu Chu |
| Erlotinib with or without bevacizumab as a first-line therapy for patients with advanced nonsquamous epidermal growth factor receptor-positive non-small cell lung cancer: Exploratory subgroup analyses from the phase II JO25567 study. Thoracic cancer 2022 Jun . Hosomi Yukio, Seto Takashi, Nishio Makoto, Goto Koichi, Yamamoto Noboru, Okamoto Isamu, Tajima Kosei, Kajihara Yusuke, Yamamoto Nobuyu |
| Characteristics of Genomic Alterations in Pericardial Effusion of Advanced Non-small Cell Lung Cancer. Frontiers in genetics 2022 6 13 850290. He Jiaxue, Hu Xintong, Chen Liguo, Liu Qiaoliang, Jiang Yanfa |
| Development of Pericardial Effusion in Non-small Cell Lung Cancer Is Associated with the Presence of EGFR/ALK Mutations. The Israel Medical Association journal : IMAJ 2022 3 24 (3): 135-139. Nardi-Agmon Inbar, Zer Alona, Peysakhovich Yuri, Margalit Ili, Kornowski Ran, Peled Nir, Iakobishvili Za |
| Testing for EGFR Variants in Pleural and Pericardial Effusion Cell-Free DNA in Patients With Non-Small Cell Lung Cancer. JAMA oncology 2022 12 9 (2): 261-265. Lee Kirsty W C, Li Molly S C, Gai Wanxia, Lau Yat Ming, Chan Allen K C, Chan Oscar S H, Lee Chee Khoon, Yeung Rebecca M W, Fung Sherwood Y H, Cheung Wai F, Chan Vivian W, Leung Linda, Kam Kenny N P, Mok Tony S |
| Relationship between the image characteristics of artificial intelligence and EGFR gene mutation in lung adenocarcinoma. Frontiers in genetics 2023 1 13 1090180. Zhou Guoping, Xu Shuhua, Liu Xiaoli, Ge Jingjun, He Qiyu, Cao Weikang, Ding Junning, Kai Xingh |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 30, 2023
- Content source: